Neutrophils are key components of the innate immune system that play important roles during infection, injury, and chronic disease. In recent years, neutrophil heterogeneity has become an emerging focus with accumulating evidence of neutrophil populations with distinct functions under both steady-state and pathologic conditions. Despite these advances, it remains unclear whether these different populations represent bona fide subsets or simply activation/polarization states in response to local cues. In this review, we summarize the varied neutrophils populations that have been described under both basal and during inflammation. We discuss the evidence that supports the existence of neutrophils subsets. Finally, we identify potential gaps in our knowledge that may further advance our current understanding of neutrophil heterogeneity.
INTRODUCTION
"Subset" is defined as a part of a larger group of related things. In terms of immunity, Th1 and Th2 lymphocytes are deemed subsets as they have different developmental pathways based on identified transcription factors and have fundamentally distinct immunoregulatory functions. When a particular lymphocyte subset enters specific environments with different cytokine milieus, they have the plasticity to alter their phenotypes to some extent, but these would continue to be part of the same subset of lymphocytes. Whether separate subsets of neutrophils exist remains unclear but could be critical for selective intervention. For example, if 2 distinct subsets of neutrophils circulate in blood and express different molecules, then targeting the recruitment of 1 subset would be possible as a form of therapy, without affecting critical functions by another subset. If by contrast all neutrophils are the same in blood, but they have the capacity to perform distinct functions in different environments, then local immunomodulation may be a necessary therapeutic strategy. Targeting all neutrophils is unlikely to work in situations like cancer where neutropenia is the biggest complication leading to infection. Therefore, strategic targeting of individual subsets may be necessary.
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Neutrophil are typically regarded as terminally differentiated cells that progress from immature neutrophils in the bone marrow (BM) to circulating mature inactive neutrophils that upon priming and subsequent activation during inflammatory conditions can extravasate into tissues and fulfill its effector functions (e.g., phagocytosis, reactive oxygen species [ROS] production and bacterial killing). It is important to note that neutrophils, which have a circulating half-life of 6-12 h in mice and perhaps longer in humans, 1,2 could rapidly change their characteristics and behavior as they get activated, age, or enter new environments. Additionally, priming or activation of neutrophils in response to various mediators during acute or chronic inflammatory conditions can extend this lifespan, thus providing increased opportunity to polarize and produce alternative effector or immuneregulatory molecules. [3] [4] [5] Finally, neutrophils respond to a myriad of different innate immune responses including sterile injury, infection, cancer, autoimmunity, and they may take on vastly different effector mechanisms in these situations. Therefore, it is not surprising that neutrophils with divergent functions (e.g., immunomodulatory, reparative) have been identified in recent years in various conditions. [6] [7] [8] [9] [10] [11] This plasticity has prompted the field to explore both phenotypic and functional heterogeneity attempting to identify neutrophil subsets as has been done for many other immune cell lineages. Different neutrophil populations have been proposed based on numerous parameters (e.g., function, cell surface markers, buoyancy, maturity, localization) under both homeostatic and pathophysiologic conditions. Collectively, these different populations characterized by distinct molecular signatures exist. In this review we will systematically summarize and discuss the evidence that suggests that neutrophils subsets exist. This concept has been proposed in the field of cancer, infection, autoimmunity, and inflammation/repair, 7, 10, [12] [13] [14] [15] however consolidation among these fields has not occurred to date. We will also try to highlight some of the potential gaps in knowledge among these fields.
Neutrophil maturation states
Neutrophils are the most abundant white blood cells in humans with an estimated 5 × 10 10 -10 11 cells produced daily. 1 Throughout their lifespan, neutrophils undergo phenotypic transitions that can be dictated by their maturation stage and the local microenvironment within the circulation and peripheral tissues (Fig. 1) . During development in the BM, neutrophils undergo sequential maturation steps to generate mature neutrophils. This immature pool can be viewed as a continuum of neutrophil precursor (NeuP) cells that can be distinguished from mature neutrophils by nuclear morphology, granular protein expression, proliferative capacity, and enhanced transcriptional activity. [16] [17] [18] These populations can be further identified by a collection of cell surface markers. In humans, immature neutrophils start to express CD15 and CD11b, followed by an elevation in CD16 and CD10 to reach full maturity. 16, 19 In the mouse system, Kim et al. 17 At the other end of the spectrum, mature neutrophils in circulation nearing the end of their lifetime may acquire a specific phenotype. This "aged" neutrophil phenotype is defined by reduced CD62L expression and the presence of CxCR4. 23, 24 In mice, CxCR4 expression is involved in homing to the BM, 25, 26 an important site of neutrophil clearance. 27, 28 The number of aged neutrophils in circulation follows a circadian rhythm, and their clearance in the BM is proposed to serve as a homeostatic signal for hematopoietic niche regulation. 23 Zhang et al. 24 also demonstrated that the microbiome through bacterial components and stimulation of TLRs and Myd88 helps to drive the aged phenotype. Further analysis revealed that these aged neutrophils displayed a distinct transcriptome profile, indicative of an activated phenotype. 24 This contributes to their enhanced recruitment and phagocytic capacity during inflammation, 29 however, conversely may also promote neutrophil-mediated tissue damage as the number of aged neutrophils correlate with pathogenesis in experimental endotoxemia and sickle cell disease. 24 Human aged neutrophils have been detected in the blood using the same markers (CxCR4 + CD62L lo ). 24 Studies have demonstrated that circulating neutrophils follow a diurnal pattern. 30, 31 Further, CxCR4 mRNA expression in neutrophils follows this pattern and coincides with the proportion of aged neutrophils in blood based on morphologic assessment. 32 Whether, these aged neutrophils home back to the BM to play homeostatic role as suggested in the mouse system is currently unclear. Interestingly, prophylactic antibiotic treatment does reduce the proportion of circulating aged neutrophils in patients with sickle cell disease suggesting that the microbiome may also influence neutrophil aging in the human context, 24 although additional evidence is required. 
Transient functional subsets of neutrophils
There are small populations of neutrophils that transiently localize in certain tissues and perform vastly different functions. Studies dating back more than 50 years have proposed the concept of marginated pools of neutrophils either adhered to vessels or completely outside the circulation that can be mobilized upon stimulation. 33, 34 Human experiments utilizing radiolabelling of neutrophils helped establish the spleen, liver, and BM as reservoirs due to slower transit times through these organs. [35] [36] [37] The lung as a neutrophil reservoir in humans remains controversial with early studies supporting an important role for marginated neutrophils in this organ, however, other studies have suggested that longer transit times through the lung in adoptive transfer experiments is dependent on the activation status of the cell. 35, [38] [39] [40] In fact, Summers et al. 40 Many neutrophils roll along the blood vessel wall of the skin microvasculature due to basal expression of endothelial selectins thereby forming a marginated pool. 41 However, these cells do not firmly arrest and eventually reenter the mainstream of blood. Why some but not all neutrophils roll in the skin microcirculation is unclear. Whether this rolling in some way signifies a specific population of neutrophils. Whether the rolling per se modifies the neutrophil phenotype is not known. Moreover, whether a small subset of these rolling neutrophils does enter the skin due to a subtle phenotypic difference and become resident or pioneer neutrophils is also unclear.
In addition to skin, the spleen and lung have been proposed to be bona fide "reservoirs" for neutrophils. There is recent evidence to suggest that neutrophils found within these organs may in fact have specialized roles. For example, there is a population of neutrophils that seems to reside in the pulmonary capillaries that were originally thought to simply be stuck as they passed through the lung microcirculation. However, recent imaging has revealed that these cells appear to tether to the vessel walls and either (1) detach, reentering the blood stream, (2) become stationary, or (3) crawl around and patrol. 42, 43 This appears to be an ongoing process that neutrophils that pass through this vascular bed do, however whether this is performed exclusively by
an as yet unrecognized subset is unclear. One group has suggested that immature neutrophils that exit BM immediately enter the lung vasculature and are retained more prevalently than mature neutrophils. 44 By contrast, a second group has suggested that older neutrophils especially those that have entered inflamed tissues ultimately return to the lung to deprime and express novel homing receptors for migration to the BM to die. 45 A third group has shown that intrapulmonary neutrophils gain the appearance of a novel subset by interacting closely with B-cells and trogocytosing membrane fragments that are displayed on their surface. 46 Importantly, upon bacterial stimulation the neutrophils found within the pulmonary vasculature rapidly increase their intravascular crawling behavior that is crucial for subsequent uptake of bacteria initially sequestered by lung capillary endothelium. 43 What is unclear from any of the aforementioned studies is whether all neutrophils or a specific subset is recruited into the lung vasculature.
Much like in the lung, in the spleen, there exists a sequestered pool of neutrophils that patrol the splenic tissue but are continuously replaced by newly recruited circulating neutrophils. 21 Indeed, parabiosis experiments revealed that these mature neutrophils are rapidly replaced by new circulating neutrophils. There is a second, progenitor population of immature neutrophils that resides in clusters juxtaposed to splenic blood vessels. These cells are not rapidly replaced.
Parabiosis experiments revealed that about a third were replaced over 2 weeks. These neutrophils were critical for helping the local splenic macrophage eradicate Streptococcus pneumonia infections. 21 Using imaging technology, mature neutrophils have been demonstrated to patrol the red pulp of the spleen and play a crucial role in encapsulated bacterial clearance in coordination with red pulp macrophage. 21 The instant macrophage grabbed S. pneumonia out of the mainstream of blood, patrolling neutrophils in the red pulp rapidly phagocytosed these bacteria. Intriguingly, neutrophils did not appear to be recruited These examples above using intravital imaging within different organs are consistent with the concept of mature marginated neutrophil population being in constant exchange with the circulation.
However, there is some evidence to support that neutrophils can potentially polarize locally within different tissue environments to become specialized populations. In human spleens, Puga et al. 47 described B-helper neutrophils in the human spleen that stimulate thymus-independent antibody production in vitro. These neutrophils that reside in the perifollicular zone of the spleen have altered cell surface markers and transcriptome profiles when compared with circulating neutrophils. 47 A similar B helper neutrophil has recently been identified in mice. 6 They demonstrated that pentraxin-3 released by these B-helper neutrophils promoted marginal zone B cell activation and homeostatic production of TI antibodies. 6 What is not clear in these studies is whether the B-helper neutrophils simply represent a polarized marginated neutrophil pool in the spleen that return to the circulation or are in fact a separate functional subset that reside long term in the perifollicular zone of the spleen. It should be noted that an independent group has been unable to isolate these same B-helper neutrophils in human spleens using the same markers and show an effect on antibody production. 48 Although in the aforementioned situations the environment cre- 
Circulating neutrophil subsets
Mature neutrophil subsets in circulation have been described in humans based on cell marker expression. CD177 is a GPI linked glycoprotein that is expressed on the plasma membrane as well as the membrane of specific granules of neutrophils. 52 The proportion of CD177 + neutrophils varies amongst individuals, some displaying bimodal (high and no CD177) or trimodal expression (high, intermediate, and no expression). Approximately 1-10% of the population displays a complete absence of CD177 + cells. [52] [53] [54] The proportion of CD177 + cells appears to be dependent on the allelic frequency of a mutation in exon7 of the protein and is also influenced by a CD177 pseudogene that also contains this mutation. 55 Individuals that are homozygotic for the wild-type (WT) sequence have a higher proportion of CD177 + neutrophils, heterozygous individuals have a bimodal or trimodal distribution of neutrophils, and individuals with mutation on both alleles do not express CD177 at all. 55 Functionally, CD177 is thought to serve as a membrane receptor and regulate the activity of the granule protein proteinase 3 (PR3) on the plasma membrane. [56] [57] [58] Due to its association with PR3, a known autoantigen in systemic vasculitis, CD177 has been linked to susceptibility to autoimmunity. In addition, CD177 + neutrophils have also been noted to increase in the gut of IBD patients and are proposed to play a protective role in maintaining gut permeability through release of IL-22. 59 This is supported by experimental work where CD177 deficient animals display aggravated pathology in response to experimental colitis. 59 While there is interperson and intraperson variability of CD177 on neutrophils, an actual role for these different subsets has not been established. These data are interesting from the perspective that all neutrophils have the capacity to produce NETs, for example, in response to PMA, but only a proportion make NETs in response to more physiologic stimuli including S. aureus.
A proangiogenic neutrophil (PAN) population has been defined in both human healthy donors and WT mice. They are characterized by the markers CxCR4 + , VEGFR1 + , and CD49d + and represent a small percentage of total circulating neutrophils (≈3%) in both mouse and human. 64 Their recruitment is VEGF-A dependent and CD49d is required for retention of neutrophils at sites of hypoxia. 64 In addition, they express significantly higher amounts of MMP9 than proinflammatory neutrophils, likely contributing to ECM remodeling. 65 Inhibition of this population results in delayed vascular sprouting in an experimental hypoxia model. 64 This may have important implications for cancer as MMP9 derived from neutrophils has been linked with tumor angiogenesis. 66, 67 A PAN phenotype has also been noted during pregnancy, displaying increased expression of VEGFR1. 68, 69 Whether the PAN subset observed during homeostasis is derived from a specialized progenitor subset or results from VEGF polarization in the blood remains to be determined.
NEUTROPHIL POPULATIONS IN INFLAMMATORY SETTINGS
Our understanding of neutrophil function under different pathologic conditions has expanded to include many immune regulatory roles and have been the topic of many recent reviews. [70] [71] [72] Investigators have adopted different nomenclature approaches to better distinguish pathogenic neutrophil phenotypes from conventional neutrophils.
Despite these efforts, the lack of defined markers, overlap between populations, heterogeneity within these populations, and opposing functions for similar populations in different disease states has sometimes made it particularly difficult to navigate. Nevertheless, they at least serve as a starting point from which subsequent characterization can be made.
Low-density neutrophils
Under normal conditions circulating neutrophils can be readily separated from PBMCs via gradient centrifugation. However, during acute and chronic inflammation a population of neutrophils with altered buoyancy characteristics colocalizes with the PBMC lower density fraction and as such has been collectively termed low-density neutrophils (LDNs). Although first described in autoimmunity 73 82 and pregnancy. 83 The overall function of these cells appears to be dependent on inflammatory stimuli and LDN numbers often correlate with disease progression in human patients. 74, 76, 84 In cancer for example, LDNs primarily have a T cell suppressive function and are often referred to as myeloid-derived suppressor cells (MDSCs; described below). 15, 74 In contrast a proinflammatory phenotype has been described for LDNs in the context of autoimmunity and infection.
In patients with systemic lupus erythematosus (SLE), Denny et al. 13 noted LDNs with an activated phenotype, produced higher levels of type 1 IFNs and were cytotoxic to endothelial cells. In leishmania infections, LDNs also display an activated phenotype along with antigen presenting cell features. 77, 79 The LDN populations themselves are heterogeneous containing both immature and mature neutrophil populations for which proportions may vary depending on disease context. 15, 19 The mature population is thought to represent an activated form of mature neutrophils in response to serum factors or stimuli present at the site of infection/injury. 15, 76, 79 Exposure to visceral leishmaniasis infected patient serum could convert normal PMNs to the LDN phenotypes. 79 Deng et al. 76 showed that direct incubation of PMNs or whole blood with MTb induced LDNs similar to those observed in individuals with tuberculosis. This has been additionally demonstrated in mouse cancer models. Sagiv et al. 15 demonstrated that that TGF-contributes to mature neutrophil conversion to mature LDNs. A subsequent experimental study demonstrated that NET-induced blood clots also contribute to this polarization in an intestinal cancer model. 75 Contrary to mature LDNs, experiments in mice suggest that the immature LDN population results from early neutrophil progenitor release from hematopoietic sites (e.g., BM, spleen) in response to stimuli. 15 It is not currently understood whether immature LDNs also undergo reprogramming in circulation and whether they necessarily have the same function as mature LDNs. Marini et al. 19 have recently provided some insight to this question in human patients by using CD10 as a marker to distinguish between mature and immature neutrophil populations.
Using samples from patients receiving G-CSF treatment, they noted that both CD10 + mature neutrophil populations (HDN and LDN) display T cell suppressive activity, which is in contrast to the CD10 − immature population that promoted T cell proliferation and cytokine release. They further validated the CD10 + marker in cancer and SLE patients and noted a higher proportion of mature neutrophils (CD10 + ) to immature neutrophils (CD10 − ) amongst LDNs from cancer patients compared with patients suffering from autoimmunity. 19 These data suggested that maybe the distribution of cells in the LDN fraction may dictate the overall function of this compartment, however further validation is needed to substantiate this view.
Myeloid-derived suppressor cells
The term MDSCs has been used extensively in the cancer field to characterize cells of the myeloid lineage based on their T cell suppressive activity. The general mechanism of suppression involves arginase-1 (Arg-1) activity and/or machinery involved in nitrosative and oxidative stress generation (e.g., iNOS). [85] [86] [87] [88] cer patients. 90 Although often referred to in the context of cancer,
MDSCs have also been noted to play roles in sepsis, infection, and cardiovascular disease. 81, 91 One major issue that has plagued the field for many years has been the lack of specific markers that distinguishes PMN-MDSCs from normal neutrophils. In fact, PMN-MDSCs are characterized as CD11b + Ly6G hi Ly6C lo in mice and CD14 − CD11b + CD15 + (or CD66b + ) for humans. 89 As a result, it is likely that most studies have inadver- with Trail-R2 receptor signaling. 92 Importantly, targeting this receptor via an agonistic antibody approach resulted in relatively specific MDSC depletion in both tumor bearing animals and cancer patients. 92, 93 A separate PMN-MDSC subset has also been characterized during endotoxemia challenge in humans. Pillay et al. 10 demonstrated that following LPS stimulation a distinct mature neutrophil population that displays hypersegmented nuclear structure and CD16 hi CD62L lo expression can mediate T cell immunosuppression via ROS and an integrin Mac-1 dependent mechanism. Proteomic analysis further supports that this is phenotypically distinct from both immature (CD16 dim CD62L hi ) and mature neutrophils (CD16 hi CD62L hi ) also present in the blood of LPS treated patients. 94 In addition, in vivo pulse-labeling also revealed similar BM and blood kinetics between CD62L dim and conventional mature neutrophils. 94 How these populations are related and whether CD62L dim neutrophils are generated by polarization of conventional neutrophils in the BM or blood still needs to be evaluated.
Collectively, these represent important advancements in the MDSC field. Additional work is needed to understand whether these novel markers are specific to these disease settings or are more generalizable to MDSCs in other inflammatory conditions. In an effort to better standardize the MDSC field, guidelines for MDSC characterization have recently been proposed. 89 Integration of the guideline framework with novel markers should provide more precision when determining their contribution to disease pathogenesis.
N1/N2 neutrophils
M1 and M2 designations have often been used to describe both proinflammatory and anti-inflammatory/reparative macrophage polarization states in response to a variety of stimuli. Fridlender et al. 8 first applied this macrophage concept to neutrophils to explain the protumoral and antitumoral roles for tumor-associated neutrophils (TANs).
Drawing on schemes established for tumor-associated macrophages (TAMs), they termed these populations N1 and N2 to describe antitumorigenic and protumorigenic neutrophil populations, respectively.
Using blockade of TGF-, they provided in vivo evidence to demonstrate that mature TANs could alter their function locally transitioning from a protumoral phenotype (N2) to an antitumoral (N1) population. 8 Additional polarization signals including angiotensin-II, type I IFNs and the proto-oncogene MET also have the ability to drive N2 or N1
phenotypes. [95] [96] [97] Transcriptomic analysis further confirmed that these N1 and N2 neutrophils represent different populations 98 and that N2 neutrophils differ from circulating PMN-MDSCs in tumor bearing mice. 14 Interestingly, TGF-also mediates the polarization of mature HDNs to mature LDNs in mice and has led to these population being termed N1c and N2c, respectively. 15 Guglietta et al. 75 suggested that
LDNs may serve as an intermediate phenotype between HDNs and N2
TANs, however additional evidence is required to appropriately characterize the relationships between these populations.
The N2 nomenclature has been further applied to the cardiovascular disease field to describe neutrophils expressing M2 macrophage markers. Ma et al. 99 have noted the progressive appearance of a mannose receptor (M2 macrophage marker) positive neutrophil population during the reparative stage in the heart following myocardial infarction. The lack of MR + neutrophils in the blood at different points following injury support the view that local polarization of neutrophils in the heart is likely responsible. However, the factors that regulate this transition remain to be determined. Using another M2 macrophage marker, chitinase Ym1, to define N2 neutrophils,
Cuartero et al. 7 demonstrated that PPAR-gamma agonist mediated protection in the brain after stroke was dependent on neutrophils and coincided with an increased number of N2 neutrophils locally.
In this study, Ym1 + and Ym1 − neutrophils could be detected in the we are bound to encounter in different pathologic situations. As our identification of different pathologically associated neutrophil phenotypes in tissues, continues the use of nomenclature that focuses on the function and/or molecules that are specifically produced by these respective neutrophil phenotypes may be more appropriate.
CONCLUSIONS
The identification of new neutrophil populations under both basal and inflammatory conditions continues to expand. Many of these noted to date appear to simply represent an activated or polarized form of conventional neutrophils generated in response to local or systemic cues.
However, there remain neutrophil populations (e.g., OLFM4 +/− , Ym +/− , PANs) that are present under steady state conditions that may represent true subsets. In both cases, additional work is required to improve our resolution of these populations, thus providing additional information regarding their origin and functions. The integration of more rigorous approaches such as single cell platforms (e.g., RNAseq, mass cytometry) will no doubt help in this regard and increase our opportunities to identify new populations. For example, Becher et al. 100 were able to identify 5 different neutrophil populations in the mouse system using a mass cytometry approach. Importantly, it will also allow for more precise evaluation of human samples (e.g., biopsy tissue) that are often plagued by low cell number. However, whether these are bona fide neutrophil subsets or just different activation states, different ages or simply neutrophils acquiring membrane proteins following interactions with other immune cells remains unclear. As such, these high throughput platforms will need to be complemented with approaches to assess functionality ideally using experimental in vivo models when appropriate or possible. The advancement of organ-on-a-chip and 3D culture systems also provide opportunities to study human neutrophil function in an environment that more closely resemble the in vivo setting than the traditional test tube. In addition to better understanding these neutrophil populations, a major challenge moving forward will also be finding better approaches to classify these distinct populations especially under pathologic conditions. 
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